The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors.
“More than 175 crore doses of Covishield have been administered in India. After Covid 19 there have been an increase in deaths due to heart attack and sudden collapse of persons. There have been a number of cases of heart attack even in youngsters. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of Covishield vaccine which have been administered to the citizens at a large number,” the petition filed by advocate Vishal Tiwari said.
